Hydroxychloroquine Market to Garner $4.6 Billion, Globally, By 2027 at 7.9 % CAGR, Says Allied Market Research

– Increase in demand for HCQ as a potential treatment option amidst the Covid-19 pandemic and surge in cases of malaria drive the growth of the global hydroxychloroquine market.

PORTLAND, Ore., Sept. 28, 2020 /PRNewswire/ — Allied Market Research published a report, titled, “Hydroxychloroquine Market by Product Type (Tablet and Active Pharmaceutical Ingredients), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Specialty Drug Store, and Retail Pharmacy), and Disease (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Coronavirus, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027.” According to the report, the global hydroxychloroquine industry generated $1.9 billion in 2019, and is expected to generate $4.6 billion by 2027, witnessing a CAGR of 7.9% from 2020 to 2027. 

Allied_Market_Research_Logo
Allied_Market_Research_Logo

Prime determinants of growth

Increase in demand for HCQ as a potential treatment option amidst the Covid-19 pandemic and surge in cases of malaria drive the growth of the global hydroxychloroquine market. However, ban in

Read More